Does not replace a balanced diet
Its more of an oversight that we take a look at. Preparing Now for Whats Coming The trajectory of GLP-1 medications massive adoption, fragmented oversight, emerging adverse events, and expanding access through minimally supervised online platforms bears similarities to other moments in health care that ultimately produced significant litigation
That means one of the most important messages for patients is this: Do not judge your health by the scale alone
The primary focus of human studies lies in overall body weight and overall metabolic indicators
Importantly, large-scale randomized trials, meta-analyses, and observational studies suggest that GLP-1RAs do not significantly increase AKI risk and may even confer renal benefits in high-risk populations
The clarification has cleared up the controversy around Derrick Lewis and his peptide use